Orchestra BioMed Holdings (OBIO) Other Non-Current Assets (2020 - 2026)

Orchestra BioMed Holdings (OBIO) has reported Other Non-Current Assets for 6 consecutive years, with $1.3 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Non-Current Assets fell 1.56% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $1.3 million (down 1.56% YoY), while the FY2025 annual figure was $1.2 million, up 21.57% from the prior year.
• Other Non-Current Assets advanced to $1.3 million in Q1 2026 per OBIO's latest filing, from $1.2 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $4.7 million in Q4 2022 and bottomed at $421000.0 in Q1 2023.
• Historically, Other Non-Current Assets has averaged $1.2 million across 5 years, with a median of $1.1 million in 2024.
• Annual changes were most pronounced in 2023 — Other Non-Current Assets plunged 83.68% — and 2024, when it surged 115.73%.
• Orchestra BioMed Holdings' Other Non-Current Assets stood at $4.7 million in 2022, then slumped by 83.68% to $769000.0 in 2023, then jumped by 32.64% to $1.0 million in 2024, then gained by 21.57% to $1.2 million in 2025, then gained by 1.94% to $1.3 million in 2026.
• Business Quant data shows OBIO's Other Non-Current Assets at $1.3 million in Q1 2026, $1.2 million in Q4 2025, and $1.3 million in Q3 2025.